跳至主要内容
临床试验/CTRI/2026/01/100003
CTRI/2026/01/100003尚未招募2/3 期

A Open Randomised Controlled Clinical Trial Of Lavangadya Churna With Dhatri Nisha Churna In Management Of Madhumeh With Special Reference To Diabetes Mellitus Type II

Dr Amarjeet Appaso Kolekar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Study The Effect OF Lavangadya Churna In Management Of Madhumeha With Special Reference To Diabetes Mellitus Type II

研究概览

简要总结

Ayurveda is ancient science which helpful in good health promotion, disease prevention, early diagnosis and Treatment of disease. Today is due to life style changing hybridisation of food, high carbohydrate diet, lack of exercise, there is number of people in worldwide and also in India suffer non communicable disease like non-insulin dependent diabetics. In Ayurveda it is correlate with disease madhumeh which is subtype prameh. Madhumeha is explained in many Ancient Samhitas. It is one of the subtypes of Vataja prameha. Acharya Vagbhata describes Prameha as frequent and copious urine with turbidity; i.e. Prabhut avil mutrata .   In India Diabetes patient Increases day by day. Diabetes Mellitus is lifestyle related and non-communicable disease. Diabetes Mellitus is a clinically identified by hyperglycaemia due to a deficiency of insulin. Most commonly type I and type II diabetes are seen all over. Type I DM is result of absolute deficiency of insulin while type II DM is due to insulin resistance, Impaired insulin secretion & increased glucose production.  Type II is the most common type of diabetes up to 95% of people with diabetes have type II. It usually occurs in middle aged and older people. Patient with diabetes often experience frequent urination (polyuria), increased thirst (polydipsia) and increased hunger (polyphagia).   Hence I have selected Lavangadya Churna for study and trial against DM with reference from Bharat Bhaishajya Ratnakar Part 4.So I selected the above said formulation.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Diagnosed patient with type II Diabetes Mellitus with hyperglycaemia on treatment one or two types of Oral Hypoglycemic Agent 2 Age 30 To 60 years irrespective of sex and socioeconomic status will be selected for study 3 Blood sugar level Fasting is more than 126 Miligram Per Decilitre and less than 200 Miligram Per Decilitre and post prandial blood sugar level more than 200 Miligram Per Decilitre And less than 300 Miligram Per decilitre with symptoms of Prameha like Prabhuta Mootrata Nocturia Trishna Kshudhadhikya Swedaadhikya Kara Pada Tala Daha Nidraadhikya 4 HbA1c 6.5 Percentage to 8 Percentage.

排除标准

  • 1 Newly diagnosed Diabetes Mellitus with or without on treatment OHA or Insulin 2 Diagnosed Diabetes Mellitus with on treatment more than two OHA 3 Fasting bsl is more than 200mg per dl and PP bsl is more than 300mg per dl 4 Known Case Of Insulin Dependent Diabetes Mellitus URINARY Tract Infection Ketoacidosis acute infection anywhere on body Gangrene retinopathy nephropathy Diabetic foot Gestational diabetes.

结局指标

主要结局

Study The Effect OF Lavangadya Churna In Management Of Madhumeha With Special Reference To Diabetes Mellitus Type II

时间窗: Initial Assessment 0th Day | Follow up on 30th 60th Day | Final Assessment 90th Day

次要结局

  • To compare the results of trial group with standard group(To study Madhumeha and Prameha in detail according to Ayurveda)

研究者

发起方
Dr Amarjeet Appaso Kolekar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Amarjeet Appaso Kolekar

Lrp Ayurvedic Medical College And Hospital PG institute and Research Centre Urun Islampur Sangali

研究点 (1)

Loading locations...

相似试验